CJC + IPA (No DAC) 20mg

CJC + IPA (No DAC) is a synthetic research peptide blend containing CJC-1295 without DAC and Ipamorelin, supplied in lyophilized form for qualified laboratory and analytical investigation. This formulation is intended exclusively for controlled in vitro research involving peptide-receptor interactions, comparative molecular signaling, peptide characterization, and multi-component assay development. The combination allows researchers to examine two structurally distinct peptide compounds within defined experimental systems. This material is supplied strictly for research use only and is not intended for human or veterinary administration, clinical application, diagnosis, treatment, or therapeutic use.

Product Designation Note:

The designation CJC + IPA (No DAC) is used for cataloging a research formulation containing CJC-1295 without DAC and Ipamorelin. CJC-1295 (No DAC) is commonly associated with modified growth hormone-releasing hormone research, while Ipamorelin is a synthetic pentapeptide investigated in ghrelin receptor-related experimental systems. This blended research material is not represented as an approved pharmaceutical, therapeutic preparation, prescription medication, or finished drug product.

Research Applications:

In controlled non-human laboratory environments, CJC + IPA (No DAC) may be utilized for investigation of:

• Comparative in vitro studies involving GHRH receptor and ghrelin receptor-associated systems
• Multi-peptide interaction and molecular signaling assay development
• Structural integrity, stability, and degradation analysis of blended peptide formulations
• Analytical characterization and comparative evaluation of distinct peptide-receptor interaction profiles

All applications are restricted to non-clinical, non-human, laboratory-based research systems.

Storage and Handling:

• Store the lyophilized research blend at approximately -20°C under controlled laboratory conditions.
• Following laboratory reconstitution, maintain at 2-8°C according to validated experimental procedures.
• Minimize unnecessary temperature fluctuations and repeated freeze-thaw exposure.
• Use appropriate aseptic laboratory practices and protect the material from moisture, excessive light, and contamination.

Product Specifications:

• Purity: Individual peptide components ≥99% when supported by the applicable HPLC analytical report or Certificate of Analysis
• Appearance: Lyophilized white to off-white powder
• Composition: CJC-1295 (No DAC) and Ipamorelin in the batch-specific stated ratio
• Solubility: Soluble in suitable laboratory-grade solvents or buffers according to experimental requirements

Compliance Notice:

CJC + IPA (No DAC) is supplied FOR RESEARCH USE ONLY as a laboratory and analytical research material. It is intended exclusively for in vitro, biochemical, molecular, receptor-interaction, and controlled experimental investigation. Neither this blended formulation nor its research presentation is represented as an FDA-approved pharmaceutical product. It is not intended for human or veterinary use, clinical administration, diagnosis, treatment, cure, prevention, or mitigation of any disease or condition. No therapeutic, hormonal, performance, body-composition, or health-related claims are made for this research material. Buyers are responsible for ensuring that acquisition, possession, storage, handling, and laboratory use comply with all applicable federal, state, and local requirements.